David Shaw D.E. Shaw & Co
David Shaw founded D. E. Shaw & Co., a pioneering quantitative investment firm that helped define systematic trading at scale. With a background in computer science, Shaw built teams that applied advanced computation to markets across equities, derivatives, and other assets. The firm remains one of the most important quant platforms in global finance, even as Shaw’s own public role has shifted over time.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$1.2B |
| 2 |
NVIDIA
NVDA
|
+$1.02B |
| 3 |
T-Mobile US
TMUS
|
+$911M |
| 4 |
Netflix
NFLX
|
+$699M |
| 5 |
Micron Technology
MU
|
+$672M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
GE Vernova
GEV
|
+$768M |
| 2 |
Robinhood
HOOD
|
+$643M |
| 3 |
SCHW
Charles Schwab
SCHW
|
+$534M |
| 4 |
Microsoft
MSFT
|
+$493M |
| 5 |
Intuit
INTU
|
+$472M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 16.33% |
| 2 | Healthcare | 8.66% |
| 3 | Consumer Discretionary | 8.33% |
| 4 | Financials | 6.44% |
| 5 | Industrials | 6.43% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
826
Flowserve
FLS
$10.2B
| $25.8M | 0.02% |
493,750
+402,087
| +439% | +$18.9M |
|
827
Texas Capital Bancshares
TCBI
$4.26B
| $25.8M | 0.02% |
325,476
+80,551
| +33% | +$5.77M |
|
828
Ouster
OUST
$2.58B
| $25.8M | 0.02% |
1,063,575
+699,849
| +192% | +$8.51M |
|
829
Telus
TU
$15.5B
| $25.7M | 0.02% |
1,597,578
+1,334,196
| +507% | +$20.7M |
|
830
Okta
OKTA
$22.8B
| $25.7M | 0.02% |
256,761
-1,130,712
| -81% | -$121M |
|
831
IDT Corp
IDT
$1.7B
| $25.6M | 0.02% |
374,126
+28,353
| +8% | +$1.62M |
|
832
RTX Corp
RTX
$282B
| $25.6M | 0.02% |
175,020
-20,807
| -11% | -$2.77M |
|
833
CALL
Albemarle
ALB
$16.7B
| $25.4M | 0.02% |
405,500
+24,400
| +6% | +$1.44M |
|
834
Pembina Pipeline
PBA
$28.3B
| $25.4M | 0.02% |
675,542
+513,773
| +318% | +$19.4M |
|
835
Lowe's Companies
LOW
$122B
| $25.4M | 0.02% |
114,402
+61,045
| +114% | +$13.6M |
|
836
CALL
Coca-Cola
KO
$396B
| $25.4M | 0.02% |
358,500
+47,900
| +15% | +$3.41M |
|
|
KLG
837
DELISTED
WK Kellogg Co
KLG
| $25.3M | 0.02% |
1,586,001
-195,730
| -11% | -$3.41M |
|
838
Innodata
INOD
$1.96B
| $25.3M | 0.02% |
493,156
-766,936
| -61% | -$30.3M |
|
839
Digital Turbine
APPS
$1.3B
| $25.2M | 0.02% |
4,278,144
-134,715
| -3% | -$554K |
|
840
Nike
NKE
$60.5B
| $25.2M | 0.02% |
355,034
+338,324
| +2,025% | +$20.3M |
|
841
IAMGOLD
IAG
$12.4B
| $25.2M | 0.02% |
3,420,948
-2,600,021
| -43% | -$18.2M |
|
842
Tyler Technologies
TYL
$14.6B
| $25.1M | 0.02% |
42,403
-37,811
| -47% | -$21.4M |
|
843
LCI Industries
LCII
$2.54B
| $25.1M | 0.02% |
275,545
+82,154
| +42% | +$7.01M |
|
844
Vulcan Materials
VMC
$35.8B
| $25M | 0.02% |
95,782
-43,045
| -31% | -$11.1M |
|
845
CALL
Estee Lauder
EL
$37.7B
| $25M | 0.02% |
308,800
+79,700
| +35% | +$5.13M |
|
846
CALL
RH
RH
$2.71B
| $24.9M | 0.02% |
131,800
+74,300
| +129% | +$13.8M |
|
847
Novavax
NVAX
$1.46B
| $24.8M | 0.02% |
3,940,960
+680,052
| +21% | +$4.5M |
|
848
DoubleVerify
DV
$2.06B
| $24.8M | 0.02% |
1,658,058
+763,583
| +85% | +$10.5M |
|
849
Plexus
PLXS
$6.33B
| $24.7M | 0.02% |
182,717
+1,519
| +0.8% | +$195K |
|
850
FirstEnergy
FE
$26.9B
| $24.7M | 0.02% |
613,696
+276,034
| +82% | +$11.4M |
|
Similar funds
David Shaw's Q2 2025 Portfolio in Review
As of Q2 2025, David Shaw held 4,838 positions worth $141B, up 26% from $112B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
David Shaw deployed $7.51B of net new capital in Q2 2025, opening 647 new positions and adding to 1,556 existing holdings. Its largest new stake was Sea Limited: 1,365,221 shares worth $218M.
By sector, the portfolio is most concentrated in Technology at 16% of assets, up from 15% a quarter earlier, followed by Healthcare and Consumer Discretionary.
On the sell side, the largest reduction was GE Vernova, an estimated $768M trimmed.
- David Shaw's largest Q2 2025 buy was Sea Limited: 1,365,221 shares worth $218M.
- David Shaw added most to Apple in Q2 2025, an estimated $1.2B increase.
- David Shaw's biggest Q2 2025 reduction was GE Vernova, cutting an estimated $768M.
- David Shaw fully exited Novo Nordisk in Q2 2025, selling an estimated $176M.
- David Shaw's ten largest holdings make up 12% of its $141B portfolio in Q2 2025.
- David Shaw opened 647 new positions and closed 532 in Q2 2025.
- David Shaw's portfolio value rose 26% quarter-over-quarter to $141B.
Based on D.E. Shaw & Co's 13F filing for Q2 2025, filed 14 Aug 2025.